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Introduction  
Background 
 For much of my undergraduate career, I have had an interest in the opioid epidemic. 
This was the first public health epidemic that I vividly remember hearing about through various 
media outlets, through public health initiatives in my community, and through class discussions 
in high school. Because of this, I find myself spending much of my time reading up on the latest 
developments of this public health crisis, talking about it with friends, and trying to find ways to 
get involved with combating it. 
 Equally important, my interests in emergency medicine stem from my training as an 
Emergency Medical Technician in New York. Having been certified for three years this May, 
much of my personal life is consumed by stories from my colleagues, hearing dispatches of 
emergencies throughout Dutchess County, and first-hand responding to these situations. The 
ever-changing environment of emergency departments is something I have always been 
fascinated by, and ultimately, I would love to spend my career working in the management of 
one. 
 These two interest areas formulated my thesis: how can two fields that I am so 
interested in have anything to do with each other? In the beginning, I thought one would only 
have impact on the other, because it made sense to me that the burden of an epidemic would 
have more of an impact on the medical field than medicine would have on a public health 
epidemic. Upon further research and discussions, I realized that I was really investigating a 
multi-faceted relationship between two relatively new and growing areas in their respective 
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fields. With that, I am excited to share with you the culmination of a year of research, 
showcasing how in order for complex public health and medical systems to be fully understood, 
the two fields must work together to combat emerging issues in their fields. 
To put the above statement into context, I argue that the opioid epidemic poses 
challenges but also opportunities for emergency departments to assess and improve their 
performance under duress for the betterment of future generations and ailments to come. In 
the subsequent chapters, I will delve into the history of emergency medicine as a specialty to 
put its recent emergence into context. Subsequently, I will discuss the opioid epidemic, its 
origin, and various causes that have contributed to its relevance and significance in public 
health. Then, I will examine data from emergency departments throughout the United States to 
track performance. After, I will describe opioid overdose cases from emergency departments 
throughout the country and strategies they have implemented to combat the epidemic. I will 
then discuss the relevance of social determinants of health. Last, I will conclude by tying in my 
thesis argument with the COVID-19 pandemic. 
Definitions 
Throughout this thesis, the term “opioid” will refer to prescription pain medications, 
heroin, and illicitly manufactured fentanyl, as defined by the Centers for Disease Control and 
Prevention. Performance will be defined as factors including wait times for overdose patients 
and wait times for all other patients. The abuse of opioids is defined as opioid use “without a 
prescription, in a way other than as prescribed, or for the experience or feelings elicited,” as 
explained by the National Institute on Drug Abuse (Mathis et al. 2018). Addiction, used 
separately from the abuse of opioids, is defined by the National Institute on Drug Abuse as “A 
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chronic, relapsing disease characterized by compulsive drug seeking and use, despite serious 
adverse consequences, and by long-lasting changes in the brain” (“Prescription Drug Abuse”, 
2011).  
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Chapter 1 – History of Emergency Medicine  
1.1 – Overview of Emergency Departments (EDs) 
Emergency departments are now a common feature of many hospitals across the 
United States, but it has not always been this way. Before the introduction of emergency 
departments, one would need to visit any available physician to treat their medical problem, 
regardless of the patient’s presenting case. In 1961, four physicians left their private practices 
to staff an emergency department in Alexandria, Virginia; this effort was led by James D. Mills, 
M.D. Similarly, 23 physicians in Pontiac, Michigan left their practices to do the same. This was 
the first moment where physicians independently realized a need for specialists in emergencies 
who were able to be around at any hour of the day (Suter, 2012). 
Prior to the formation of the emergency medicine specialty, those who needed 
emergency care would be seen by whatever physicians were available, regardless of their 
specialty. Even if a hospital were a large university-based teaching hospital, it is possible that an 
appropriate physician would not be available without dedicated emergency specialists around. 
Second, the same group of symptoms can be diagnosed as many different diseases. If a patient 
arrived at a hospital presenting with abdominal pain and vomiting, this could be due to 
dehydration, alcohol poisoning, or even appendicitis. Without the appropriate emergency 
medicine physician or practitioner who is trained to diagnose and stabilize patients across a 
large array of ailments, the patient might need to be seen by a cardiologist, a neurologist, an 
endocrinologist, and a gastroenterologist, among other specialties before attaining a proper 
diagnosis out of multiple differential diagnoses (Suter, 2012). The formation of an emergency 
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medicine specialty greatly improved both the timeliness and appropriateness in which these 
patients were seen by a physician and stabilized, making for a safer and more effective system 
for emergent medical cases. 
In August of 1968, the American College of Emergency Physicians was founded, initially 
to develop education materials specific to emergency medicine. Soon after, in 1972, the 
American Medical Association recognized emergency medicine as a specialty and created the 
American Medical Association Section of Interest on emergency medicine. The next year, the 
federal government passed the Emergency Medical Services Systems Act (Public Law 93-154) to 
fund local and regional EMS services (Suter, 2012). Additionally, funds from the Department of 
Health, Education, and Welfare (1972), the Robert Wood Johnson Foundation (1973) helped 
jumpstart emergency medicine as a specialty (Kellermann et al., 2013). On the private side, 
Advanced Cardiac Life Support and Advanced Trauma Life Support courses were created for 
continuing EMS education. The first emergency medical residency program was started in 1970 
at the University of Cincinnati, sparking the creation of more emergency medical education 
programs for medical residents (Suter, 2012). Ultimately, the success of the initial work on 
developing the emergency medicine specialty led to the creation of The American Board of 
Emergency Medicine in 1976. This board then received its specialty board approval in 1979 to 
make emergency medicine the 23rd medical specialty in the U.S. (Suter, 2012). 
With the arrival of emergency medicine in the hospital also came the introduction of the 
911 system. In 1957, the National Association of Fire Chiefs recommended the use of a single 
number for reporting fires, rather than calling the local firehouse. This was supported by other 
Federal Government Agencies and government officials, leading to the President’s Commission 
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on Civil Disorders working with the Federal Communications Commission (FCC) for a permanent 
solution. In November of 1967, the FCC met with the American Telephone and Telegraph 
Company (AT&T) to create a solution, and in 1968, it was announced that 9-1-1 would be the 
emergency code throughout the U.S. This number was chosen because it is brief, easily 
remembered, and can be dialed quickly. It also is a unique number, never having been 
authorized as an office code, area code, or service code, and it met long-range numbering plans 
and switching configurations of the telephone industry (“History of 911”, 2017). It is strongly 
encouraged for 911 to be called for those who are experiencing medical emergencies, 
particularly an overdose, as important life-saving measures can be taken to ensure the patient’s 
life is saved.  
Presidents John F. Kennedy and Lyndon B. Johnson’s interest in public health, 
specifically in treating heart disease, cancer, trauma, and stroke is much of the reason why 
emergency medical services came to be. Much of the strategies to combat these included 
establishing regional associations centered around academic medical centers to improve 
research, education, and patient care, with government involvement to make sure the 
advances were properly disseminated. As a result, Regional Medical Programs (RMP) were 
created. These programs expanded the training of health care providers, promoted a 
philosophy of technologically advanced and intensive health care, and moved control of health 
care improvements from the local to the regional level, with the regional associations forming 
independently based upon community needs. Funding for these programs created numerous 
EMS systems and trained many Emergency Medical Technicians. Additionally, regionalized 
health care became of focus, meaning that these EMS providers would take trauma patients to 
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specialty centers, rather than a local regional hospital. Initially, there was a lack of legislation, 
standards, and regulations for EMS providers, creating a disorganized system of variable patient 
care, but in the 1960s, improved technologies, funding, and protocols strengthened EMS, 
proving it to be a vital and important contribution to emergency medicine (Shah, 2006). 
1.2 – Theoretical Framework to Explain Emergency Departments 
 In thinking of STS theory that accurately reflects the founding of emergency medicine as 
a specialty, Bruno Latour’s actor-network theory comes to mind. Latour instructs us to “follow 
the actors” as they assemble social networks with successful results. This is best explained by 
the use of actor-network theory to explain the success of the Portuguese Caravel in sailing 
around Africa when previous ships failed to do so. If we view this ship as only a ship, we miss 
seeing how the network of relationships contribute to its success, including the design and 
physical structure of the ship and the trained captains who employ technology to successfully 
sail. The specialized language of actor-network theory speaks of “assembling the social,” of 
“heterogeneous engineering” (a kind of multi-tasking), of “enrollment” and “recruitment” of 
“allies.”  Networks that survive must successfully face “trials of strength.” 
 In a similar vein, emergency departments are not only identifiable departments within a 
hospital, but a network of relationships that contribute to its success. There are not only 
physicians, but there are nurses, patient care technicians, respiratory technicians, physician’s 
assistants, the physical structure of an emergency department, the inclusion of in-house x-ray 
laboratories, and more, that have turned the basic emergency room into what it has become 
today. Nevertheless, emergency departments are ever-evolving environments that must 
continue to adapt and evolve to situations that arise. 
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 Take, for instance, the yearly influenza outbreak. From personal experience, I have 
witnessed Vassar Brothers Medical Center shape its emergency department three separate 
times in one flu season to adapt to the evolving nature of the virus. First, all flu patients were 
seen as normal, meaning brought into the regular home of the emergency department to get 
the care they need. I then witnessed the emergency department separate flu patients into 
another area of the hospital, one that was normally used as a conference space. Once the 
spread of the flu decreased, patients were seen as normal in the regular home of the 
emergency department. Opioid patients can be seen in a similar way, such as breaking them off 
into a separate, dedicated ward of the emergency department for substance abuse treatment. 
Chapter 4 describes practices taken by emergency departments that have done this. 
 This is all to say that emergency departments can be thought of as adaptive ecosystems; 
they are evolving entities that must adjust in the face of environmental challenges. What must 
an emergency department do if suddenly the opioid supply explodes, if either drug demand or 
drug supply goes through the roof, or what if a new virus suddenly appears on the scene? The 
following chapter will focus in on the background of the opioid epidemic to provide further 
context of why emergency departments must adapt to new challenges.  
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Chapter 2 – The Opioid Epidemic 
 Opioids are medications used to relieve pain. They reduce the intensity of pain signals 
reaching the brain and affect those brain areas controlling emotion, which diminishes the 
effects of a painful stimulus (“Prescription Drug Abuse”, 2011). Drugs that fall into these 
categories include hydrocodone, oxycodone, morphine, codeine, fentanyl, heroin, and more. 
While many opioids are used for medical purposes (i.e. before or after surgeries to alleviate 
pain, relieve dental pain, and even as cough and severe diarrhea relievers), a rising problem in 
society is the non-medical usage of opioids. The following chapter will dive into selected issues 
and topics surrounding the opioid epidemic. 
2.1 – Overview of the Opioid Epidemic 
As of October 16, 2017, the opioid epidemic was recognized as a public health 
emergency (Jones et al., 2018). The Centers for Disease Control and Prevention began to use 
the term “epidemic” to describe this event in 2011, and little evidence has been provided to 
change the status to anything other (Freeman et al., 2018). Since 1999, prescription opioid 
overdose deaths have quadrupled (Ayres et al., 2018). In 2017, 47,600 deaths were caused by 
opioid overdoses (“Drug Overdose Deaths”), and 35% of these deaths were attributed to 
prescribed opioids (“Overdose Deaths Involving Prescription Opioids”); for comparison, in this 
same year, the number of deaths from motor vehicle accidents was 37,133 (“USDOT”). 
Currently, the states with the highest number of opioid overdose deaths are West Virginia (57.8 
per 100,000), Ohio (46.3 per 100,000), Pennsylvania (44.3 per 100,000), Washington, D.C. (44.0 
per 100,000), and Kentucky (37.2 per 100,000) (“Drug Overdose Deaths”). 
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After the introduction of pain standards from The Joint Commission, a report found that 
the incidence of opioid over-sedation more than doubled from 11.0 to 24.5 per 100,000 
inpatient hospital days (Vila et al., 2005). The prescribing of opioids saw an increase between 
1999 and 2011, which increases the deaths and overdoses associated with prescribing (Hallvik 
et al. 2018). This may be due to their use for pain, as they are intended for short-term pain 
relief. However, their addictive nature has caused between 8 and 12 percent of patients who 
are prescribed opioids to develop an opioid use disorder (Hallvik et al., 2018); in context, four in 
five new heroin users started out misusing prescription pain killers (Jones, 2013). Non-medical 
opioid usage is also a large contributor for the rise in opioid use. Non-medical use, however, is 
related to physicians prescribing opioids to patients. In 2017, there were 58.7 opioid 
prescriptions written for every 100 residents, by state and county (“Prescription Opioid Data”). 
Even more specific is the desire in the 1980s and 1990s to treat pain previously untreated. 
Epidemiologists suggest that the low perceptions of risk or harm from these medications are 
associated with the non-medical use of opioids (Mathis et al., 2018).  
Although opioids technically require a prescription, a substantial amount of the use is 
non-prescription use; this includes the use of opioids by friends and families of those individuals 
with a prescription to attain opioids and use without a prescription. In a 2018 study, it was 
found that 53% of individuals who have prescription opioids are given them by family or friends 
(Mathis et al., 2018). Opioids have a high potential to cause addiction, even when prescribed 
and taken appropriately.  
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2.2 – Pain and Opioids 
Pain is one of the first signs we recognize after an injury. Before the 1800s, though, 
physicians viewed pain as a “consequence of aging” (Jones et al., 2018). During this same time, 
there were no regulations on using cocaine and opioids, which resulted in widespread 
marketing and prescribing of these drugs for many different conditions. In response to growing 
abuse of heroin for non-medical purposes, the Harrison Narcotic Control Act of 1914 was 
passed; however, this act did not restrict physicians on prescribing opioids (Terry, 1915). 
For much of the late 20th century, patients with pain were encouraged to wean 
themselves off of opioids until they had a life expectancy of weeks, creating a fear known as 
“opiophobia” (Jones et al., 2018). Studies into this fear discovered an under-reliance of opioid 
analgesics and an under-treatment of pain. Furthermore, in 1980, a letter to the editor of the 
New England Journal of Medicine by Jane Porter and Hershel Jick, M.D., stated that it was rare 
for patients to develop an addiction to opioids if they had no prior history of addiction (Porter 
and Jick, 1980), but there is little scientific evidence to support this (Jones et al., 2018). 
Two large organizations then took a stand on pain as an important finding that should 
be addressed upon physician examination of a patient. First, the World Health Organization had 
their Cancer Pain Monograph, addressing the under-treatment of post-operative pain, as well 
as cancer pain, prompting publications questioning why opioids were not given to patients with 
chronic pain (Jones et al., 2018). Second, In the 1990s the Joint Commission on Accreditation of 
Hospitals recognized pain as the fifth vital sign in the United States, which resulted in doctors 
asking about pain (Baker “TJC Pain Standards”, 2017). While this effort was meant to improve 
patient experience, the literature believes it may have had the unintended effect of vastly 
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increasing use of pain medications, some of which may result from inappropriate prescriptions 
for opioids (Jones et al. 2018). The Joint Commission began publishing standards for pain 
management in 2000, emphasizing that physicians conduct their examinations using 
quantitative assessments of pain, as recommended by the Institute of Medicine (Baker “History 
of TJC Pain Standards,” 2017). This mandating of assessing pain led to physicians heavily relying 
on opioids due to a fear of federal healthcare funds being removed if their practice was not up 
to the standards of The Joint Commission (Jones et al., 2018). Pharmaceutical companies also 
pushed for the use of opioids as a treatment option, and as seen in the following paragraphs, 
the effect of this is still evident today. 
2.3 – Pharmaceutical Involvement in the Opioid Epidemic 
The history of how opioids were advertised may explain in part how the opioid epidemic 
came to be. The advertising of OxyContin, a drug manufactured by Purdue Pharma in Stamford, 
Connecticut, is one of the first instances of opioids being promoted for use for pain 
management. Around the same time that the Joint Commission began its “pain as the fifth vital 
sign” movement, Purdue sponsored pain-management and speaker-training conferences, 
targeted toward healthcare providers. Purdue used marketing data to influence what 
physicians prescribe. They targeted the physicians who had the highest rates of opioid 
prescription nationwide (Van Zee, 2009). A bonus system was also put in place to increase the 
sale of OxyContin among pharmaceutical representatives. These sales representatives were 
also involved in a starter coupon program for patients, providing patients with a free-limited 
time prescription for as little as 7 to as many as 30 days (Van Zee, 2009). During this period, the 
number of prescriptions for patients with pain not related to cancer saw a tenfold increase, and 
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prescriptions for patients with cancer-related pain increased by four times (Van Zee, 2009). The 
business approach taken by Purdue increased and influenced the number of prescriptions of 
OxyContin, therefore increasing the exposure of the drug to consumers. 
To put this into context, in 2018, 46,802 deaths were caused by opioid overdoses, 
making up 69.5% of all drug overdose deaths. Though the number of new cases of opioid 
addiction happen annually throughout the United States is unreported, it is of note that roughly 
21 to 29 percent of patients prescribed opioids for chronic pain misuse them (“Opioid Overdose 
Crisis”, 2020). Emergency department visits for opioid overdoses rose 30% in all parts of the 
United States between July 2016 and September 2017 (“Opioid Overdoses Treated in 
Emergency Departments”, 2018). With these high numbers, root causes of these deaths are 
being further examined, as illustrated by recent lawsuits involving pharmaceutical companies 
throughout the nation. 
Today, the actions of pharmaceutical giants like Purdue Pharma are coming under public 
scrutiny. Over the last few years, over 2,500 local governments and numerous states filed 
lawsuits against some of the country’s largest names in pharmaceuticals, physicians, and more 
of the major players in the opioid crisis. Among these companies and individuals are the Sacker 
family, whom are known for founding Perdue Pharma. These lawsuits were lumped together, 
mainly in Summit and Cuyahoga Counties in Ohio, and were scheduled to have a lawsuit on 
October 21st, 2019. Prior to this lawsuit, Purdue Pharma filed for Chapter 11 bankruptcy 
protection as a part of a settlement deal one month prior and was mandated to pay $3 billion 
of the Sackler family’s money to plaintiffs, thus excluding them from the trial. Just a few hours 
before it was scheduled to begin, pharmaceutical giants Teva Pharmaceuticals, McKesson, 
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Cardinal Health and AmerisourceBergen agreed to settlements with the two Ohio counties 
totaling roughly $260 million. The only pharmaceutical giant that has yet to agree to a 
settlement is Walgreens, but because they were sued as both a distributor and a pharmacy, the 
company will likely be included into a lawsuit by the Ohio counties against pharmacies (Dwyer, 
2019). 
2.4 – Government Involvement in the Opioid Epidemic 
In 2017, to try to address the opioid epidemic, President Trump awarded a total of $485 
million in grants to all states through the Department of Health and Human Services, to be 
distributed over two years. In a statement, Health and Human Services Secretary Tom Price, 
M.D., said: 
“These grants aim to increase access to [substance abuse] treatment, reduce unmet 
need, and reduce overdose related deaths. I understand the urgency of this funding; 
however, I also want to ensure the resources and policies are properly aligned with and 
remain responsive to this evolving epidemic. Therefore, while I am releasing the funding 
for the first year immediately, my intention for the second year is to develop funding 
allocations and policies that are the most clinically sound, effective and efficient.” 
 
These funds are aimed to combat five different context areas of the epidemic: strengthening 
public health surveillance, advancing pain management practice sans opioids, improving access 
to treatment and recovery services, targeting availability and distribution of overdose-reversing 
drugs, and supporting research. Ultimately, Dr. Price stated that “Through a sustained focus on 
people, patients, and partnerships, I am confident that together we can turn the tide on this 
public health crisis” (“Trump Administration awards grants to states to combat opioid crisis”, 
2018). Since then, sub-branches of the Department of Health and Human Services have 
specified funds for particularly vulnerable populations, as well as for expanding treatment, 
Through the Substance Abuse and Mental Health Services Administration (SAMHSA), $9.8 
 18 
million was awarded in September 2017 to “support family-based services for pregnant and 
postpartum women with a primary diagnosis of a substance use disorder, including opioid use 
disorders” via the Comprehensive Addiction and Recovery Act. This act also distributed funds to 
increase the availability of long-term recovery support for substance abuse and addiction, 
provide training and medication for emergency treatment of opioid overdose, and expand 
access to FDA-approved drugs or devices for emergency treatment of opioid overdose (“Better 
Prevention, Treatment & Recovery Services”, 2018). 
 These funds have improved some nationwide statistics. From 2017 to 2018, there was a 
4.1% decline in drug overdose deaths. This is the first time in over two decades in which fewer 
Americans died of drug overdoses than the year before. However, there are rising death rates 
of other substances, such as methamphetamines, and further work from the Department of 
Health and Human Services is to be done to lower numbers more (“HHS By the Numbers”, 
2020). 
2.5 – Prescription Drug Monitoring Programs and Opioids Prescribed in Emergency 
Departments 
Prescription drug monitoring programs (PDMPs) are electronic registries maintained 
within states of prescription drugs being dispensed (Winstanley et al., 2018) and their 
expansion is another way in which the medical profession and state/federal government are 
working to stem the opioid epidemic. According to the CDC, PDMPs are “among the most 
promising state-level interventions to improve opioid prescribing, inform clinical practice, and 
protect patients at risk” (“What States Need to Know About PDMPs”, 2017). All states but 
Missouri have legislation establishing these programs. Physicians can use PDMPs to detect 
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patterns of drug abuse, and also stop “doctor shopping” or prescription duplication as they 
maintain the records of controlled substance prescriptions issued to a patient (Ayres et al., 
2018). These programs also reduce the fraudulent or overprescribing of opioids by physicians 
(Islam et al., 2014). The absence of these programs in the 1990, potentially in combination with 
Purdue Pharmaceutical’s promotion of OxyContin, may have been the cause of over-
prescription. It is important to note that, once these programs are implemented, it takes time 
for them to be fully utilized. In addition, until the majority of providers are using PDMPs, 
population-level impact is unlikely (Winstanley et al., 2018). 
 These programs are important, especially considering the history of the rates of opioid 
prescribing patterns. Beginning in 2006, there was a steady increase in the overall national 
opioid prescribing rate, with the total number of prescriptions dispensed peaking in 2012 at 
more than 255 million and a prescribing rate of 81.3 prescriptions per 100 U.S. residents. After 
2012, the prescribing rate had fallen through 2018, with 51.4 prescriptions per 100 U.S. 
residents, giving a total of more than 168 million total opioid prescriptions (“U.S. Opioid 
Prescribing Rate Maps”, 2020). Based on the introduction of PDMPs during this time frame, it is 
clear that they are helping limit the increase in unnecessary opioid prescriptions. 
An important link between the opioid epidemic and emergency departments is the 
prescribing patterns of opioids by emergency department physicians and other prescribing 
providers. Opioids were given during emergency department visits at 53.4 visits per 1,000 
adults visiting the emergency department during the study period, and opioids were further 
prescribed at discharge for at-home continuity of care at 38.4 visits per 1,000 adults visiting the 
emergency department during the study period (Rui and Schappert, 2019). 
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Figure 1 – Rate of emergency department visits with opioids given in emergency departments, prescribed at 
discharge, or both, per 1,000 adult women and men: United States, 2016 
(Source: Rui and Schappert, 2019) 
 According to a 2020 report from the CDC, exposure to an opioid prescription in the ED 
has been identified as a potential risk factor for long-term use, with one study reporting that 
17% of patients who filled their first opioid prescription for a minor painful condition were still 
receiving opioids one year later (Pinyao et al., 2020) (Stephenson, 2020). Could there be a more 
effective way of treating pain in emergency departments? To address this question, it is useful 
to consider the performance emergency departments and how this might be further affected 
by the opioid epidemic. The following chapter will examine emergency department 
performance, using a variety of measures. 
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Chapter 3 – Emergency Department 
Performance 
 Emergency departments are utilized by individuals throughout the United States. With 
roughly 43.3 visits per 100 United States residents in 2017, patients with many different 
diagnoses, treatments, and outcomes are seen in emergency departments. A major 
performance metrics for emergency departments nationally is wait times.  
3.1 – Wait Times and General Emergency Department Data 
 Wait times in emergency departments are important measures of tracking hospital 
efficiency. In many cases, the emergency department is a patient’s first entry into a hospital, so 
any delays to care in that time could affect their outcome. In general, shorter wait times lead to 
better clinical results and higher patient satisfaction (Hall et al., 2013; Horwitz et al., 2010). In a 
2010 paper written by Dr. Leora Horwitz and colleagues, it was found that in 2006, the median 
wait time among acutely ill (emergent and urgent) patients was 27.5 minutes; the median 
emergency department was able to evaluate 78.3% patients within the recommended triage 
time of one hour (Horwitz et al., 2010). But what has changed since then? 
The most current hospital emergency department data, which include information on 
wait times nationwide, are collected as part of the Centers for Disease Control’s National 
Hospital Ambulatory Care Survey (NHAMCS). The NHAMCS collects data on the utilization and 
provision of ambulatory care services in hospital emergency and outpatient departments, as 
well as ambulatory surgery locations. The survey’s findings are based on a national sample of 
visits to the emergency departments, outpatient departments, and ambulatory surgery 
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locations of noninstitutional general and short-stay hospitals (“Ambulatory Health Care Data”, 
2020). Datasets from each year’s survey can be found publicly online through the CDC’s website 
and are released from the Ambulatory and Hospital Care Statistics Branch of the CDC. 
The most recent study using NHAMCS was conducted from December 26, 2016, through 
December 24, 2017 (“NHAMCS”, 2017); 234 emergency departments throughout the country 
participated in the survey; 331 emergency service areas within emergency departments were 
identified, and 240 of these areas responded fully or adequately, defined as having completed 
patient record forms for at least one-half of their expected visits based on the total number of 
visits during the aforementioned time period. The study reported that about 138,977,000 total 
visits to emergency departments (“NHAMCS”, 2017). About 40% of patients, waited less than 
15 minutes to see a physician, advanced practice registered nurse, or a physician assistant, and 
32.9% of patients waited between 15 minutes and an hour. Limitations of these summary 
tables include that the numbers for wait times are not stratified by chief complaint (i.e., the 
main reason why the patient presented themselves to the emergency department), but 
nonetheless the data provide insight into trends in wait times and patients’ chief complaints. 
About 0.1% of all visits to the emergency room were for opioid-related disorders, 0.2% were for 
intentional overdoses, and another 0.2% were for unintentional overdoses. Though these 
numbers are small, it is of note that the largest percentage of chief complaints in this table is 
5.7%, which is for “Other symptoms, signs, abnormal findings and ill-defined conditions,” and 
the next largest percentage is 5.0% for abdominal pain. This indicates that there is a wide 
variety of complaints patients come into the emergency department for, which leads to smaller 
percent distributions overall (“NHAMCS”, 2017).  
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In comparison, looking at the 2016 tables provide insight into potential trends in 
hospitals. The 2016 survey was conducted from December 28, 2015, through December 25, 
2016; 265 emergency departments throughout the country participated in the survey; 385 
emergency service areas within emergency departments were identified, and 271 of these 
areas responded fully or adequately, defined as having completed patient record forms for at 
least one-half of their expected visits based on the total number of visits during the 
aforementioned time period. A total of 39% of patients waited less than 15 minutes to see a 
physician, advanced practice registered nurse, or a physician assistant, and 31.6% of patients 
waited between 15 and 59 minutes to see one of the mentioned providers. It is of note that 
more than one third of patients spent between 2 and 4 hours in the emergency department, 
which is roughly 34% of all patients. Additionally, 0.2% of cases were for intentional overdoses, 
and 0.1% were for opioid-related disorders (“NHAMCS”, 2016). 
In both years, the exact number of diagnoses of opioid-related disorders had an 
estimate that did not meet NCHS standards of reliability; thus, it was not reported in the 
summary tables. This implies that though there are cases of this occurring in the emergency 
department, there are not enough to have a precise count. However, percent distributions are 
provided, which helps in seeing these cases compared with other chief complaint 
presentations. Again, though these are small percents, the distribution of case presentations is 
extremely wide in emergency departments. 
In comparison to the Horowitz analysis from 2010, the number of patients being seen in 
the recommended triage time has slightly decreased; the figures from the 2006 data report 
78.5% of patients being evaluated in about an hour, whereas around 73% of patients in 2017 
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and 70.1% of patients in 2016 were seen in an hour. Though 2006 data are not viewable on the 
CDC website, it is of note that there are no data reported for opioid-use disorder emergency 
room visits on the published NHAMCS study from 2007, which may imply that there was not a 
need for this data in previous years. However, the more recent numbers support my thesis 
claim that opioids are challenging emergency department performance as measured by wait 
times. 
 In addition to the NHAMCS, the CDC maintains data briefs on their website through the 
National Center for Health Statistics (NCHS). These briefs provide key findings from various 
health-related studies and reports using data from the CDC. The briefs also provide context to 
the data collected by the CDC, making way for future implications on policy, healthcare 
delivery, and ways to improve standard of care. The following information was found using the 
search tool from the NCHS Data Briefs page, using the search term “emergency.” 
 In a 2012 brief from Esther Hing, M.P.H., and Farida Bhuiya, M.P.H., 2009 emergency 
department wait times were analyzed. Between 2003 and 2009, mean emergency department 
wait times increased from an average of 46.5 minutes to 58.1 minutes; longer wait times were 
seen in urban areas (62.4 minutes) as compared to non-urban areas (40.0 minutes). The 
increase in wait time was directly related to the annual emergency department visit volume, 
with the average wait time being 33.8 minutes in EDs with less than 20,000 annual visits and 
69.8 minutes in EDs with 50,000 or more annual visits (Hing and Bhuiya, 2012). It was also 
reported that among those hospitals with triage systems (see Figure 2), 53% of patients were 
seen within the recommended triage time of one hour. In comparison to the 2010 study by 
Horwitz et al., we see that emergency departments are less efficient in getting patients seen 
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within the recommended triage time; 67% of patients in 2006 who were triaged to be seen in 
an hour or less were seen in that time (Horwitz et al., 2010). 
An important factor to consider when looking at emergency department wait times is 
the urgency of the patient’s case. Those entering the emergency department for an opioid 
overdose are considered immediate cases in the emergency department, meaning that because 
of a high potential for death, these patients must be immediately seen by a healthcare 
provider. Other triage levels include emergent (must be seen between 1 and 14 minutes), 
urgent (must be seen between 15 and 60 minutes), semiurgent (must be seen between one to 
two hours), and nonurgent (can be seen after two hours) (Gilboy et al., 2011). As seen in the 
2012 CDC brief by Hing and Bhuiya, most emergency department visits in 2009 were for urgent 
patients, whose mean wait time was 63.3 minutes. Immediate patients made up 2% of all 
emergency department visits, with a mean wait time of 28.9 minutes. This high number of 
urgent patients may be due to patients seeking out emergency department care rather than 
primary care due to lack of a timely option elsewhere. 
 
Figure 2 – Mean emergency department wait time for treatment, by urgency of patient care: United States, 2009 
(Source: Hing and Bhuiya, 2012) 
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3.2 – Crowding 
 As defined by the American College of Emergency Physicians, emergency department 
crowding is defined as when there are inadequate resources to meet patient care demands that 
lead to a reduction in the quality of care (Asplin et al., 2003). Overcrowding presents a 
consistent problem in U.S. emergency departments in receiving care in a timely manner. It also 
presents a case for supply and demand issues in receiving treatment. The function of urgency 
for demand of non-emergent versus emergent care differs in that non-emergent, known 
conditions often see similar procedures on a routine basis, yet when emergent cases appear, 
this leads to an increase in unscheduled procedures. This is of importance, as those receiving 
care for non-emergent, chronic cases of illness have different organizational and supply 
characteristics than those needed for emergency medical care (Asplin et al., 2003). 
 The below model comes from a 2003 paper from Dr. Brent Asplin and colleagues titled, 
“A Conceptual Model of Emergency Department Crowding.” Illustrating the various factors that 
go into the demand for emergency medical care, the model also suggests reasons for 
emergency department overcrowding. The input component of ED crowding in our conceptual 
model includes any condition, event, or system characteristic that contributes to the demand 
for ED services. In the throughput component, the four factors listed are potential contributing 
factors of overcrowding, highlighting the need to look internally at ED care processes and 
modify them as needed to improve their efficiency and effectiveness, especially those that have 
the largest effect on length of stay and resource use in the ED. The output component 
highlights the cyclical nature of emergency department crowding, illustrating different 
outcomes of entering an emergency department for treatment. It is widely reported that ED 
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crowding stems from the inability to move admitted patients to an inpatient bed, forcing the ED 
to board admitted patients until inpatient beds are available, and effectively reducing the ED's 
capacity to care for new patients. Additionally, those who walk in will in turn wait longer to be 
seen by physicians, bringing us back to the beginning of the cycle. Keeping patients in the 
emergency department longer also leads to healthcare practitioners being taken away from 
evaluating new patients, delaying care and ultimately contributing to longer wait times (Asplin 
et al., 2003).  
 
Figure 3 – Input-Throughput-Output Conceptual Model of Emergency Department Crowding 
(Source: Asplin et al., 2003) 
 
 One important consequence of emergency department overcrowding that affects 
patients being brought in via emergency medical services is ambulance diversion. Seen in many 
major hospitals across the country, this occurs when the emergency department beds are close 
to or have reached capacity and hence stop accepting new patients. Emergency departments 
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remain in an ambulance diversion until beds become available when patients are moved out of 
the department, either being discharged home, admitted as inpatients into the hospital, or pass 
away (Hall, 2013). If ambulances are being diverted to other hospitals, this can delay patient 
care for diverted patients. 
 With delayed patient care comes risk of quality of patient care. A 2011 study by Dr. 
Adam J. Singer and colleagues investigated the association between length of emergency 
department boarding and mortality. The researchers found that mortality increased with 
increasing board times, from 2.5% in patients boarded less than 2 hours to 4.5% in patients 
boarding 12 hours or more (Singer et al., 2011). However, a 2019 study by Dr. Moon O. Lee and 
colleagues measured patient safety and quality outcomes using patients admitted to alternative 
care area inpatient beds; these include beds located in inpatient hallways, cardiac 
catheterization labs, and endoscopy rooms. Quality outcomes were measured as transfers to 
the intensive care unit, mortality, hospital-acquired infections, falls, and 72-hour hospital 
readmission. Alternative care inpatient beds were found to have shorter lengths of stay than 
those admitted to inpatient beds (roughly 2.7 days as compared to 3.4 days, respectively) (Lee 
et al., 2019). This implies further work is to be done to see if boarding patients in alternative 
care area inpatient beds is appropriate for emergency departments to adopt to combat 
crowding. 
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3.3 – The Role of Addiction Medicine 
 Hospital emergency departments serve an important role in medicine, especially for 
those with limited options for care due to insurance coverage. Recently, there has been a push 
for more primary care physicians given that the principal reason patients visit emergency 
departments for non-emergent outpatient care is due to the lack of timely options elsewhere 
(Gonzalez et al. 11, 2011). 
 Addiction treatment helps the individual stop using drugs, maintain a drug-free lifestyle, 
and achieve productive functioning in their life. Because addiction is a disease, most people 
cannot stop using drugs for a few days and be cured permanently. Rather, many patients 
require long-term or repeated episodes of care to maintain sustained abstinence and recovery 
(“Principles of Drug Addiction Treatment”, 2018). Methadone treatment has been shown to 
increase participation in behavioral therapy and decrease both drug and criminal behavior, but 
individual treatment outcomes depend on the extent and nature of the patient’s addiction, the 
appropriateness of treatment and related services used to address those addictions, and the 
quality of interaction between the patient and his or her treatment providers. 
 
Figure 4 – Relapse Rates of Chronic Conditions 
(Source: “Principles of Drug Addiction Treatment”, NIDA, 2018) 
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There are currently three drugs used for the treatment of opioid-use disorder: 
methadone, buprenorphine, and naltrexone. All three are demonstrated to be effective forms 
of medication for treating opioid-use disorder, but not all of them are appropriate for all 
patients. For instance, naltrexone requires patients to undergo a minimum seven- to 10-day 
detoxification before initiation, which may not be right for patients who need to begin 
treatment immediately. Similarly, some patients are averse to taking opioid agonist drugs as 
part of treatment and may therefore prefer the use of naltrexone, an opioid antagonist (Jones 
A. et al., 2018). According to federal data, 41.2 percent of nearly 12,000 drug addiction 
treatment facilities throughout the United States offer one form of medication-assisted 
treatment, or MAT (Jones A. et al., 2018). Twenty-three percent of facilities report offering two 
or more forms of MAT, which are mostly naltrexone and buprenorphine. Yet only 2.7 percent of 
facilities offer all three forms of MAT, of which 234 (73.4 percent) report accepting Medicaid. 
Eight states do not have any facilities that report offering all three forms of MAT, and 14 states 
do not have a facility offering all three forms of MAT that also accepts Medicaid. To highlight 
this, a 2018 HealthAffairs article included maps using data from The Substance Abuse and 
Mental Health Services Administration’s National Survey of Substance Abuse Treatment 
Services that represent the growing need for more access to addiction facilities and treatment. 
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Figure 5 – Substance Abuse Facilities Offering Medication-Assisted Treatment, 2016 
(Source: “Where Multiple Modes Of Medication-Assisted Treatment Are Available”, HealthAffairs, 2018) 
 
 
 
Figure 6 – Substance Abuse Facilities Offering All Three Forms Of Medication-Assisted Treatment, 2016 
(Source: “Where Multiple Modes Of Medication-Assisted Treatment Are Available”, HealthAffairs, 2018) 
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These maps highlight significant gaps in medicated-assisted treatment programs 
throughout the United States. Most of these facilities are found in the Southwest and 
Northeast, regions with highly populated urban cities, whereas the remainder of the country 
has limited to no access. What is particularly striking is the lack of all-MAT facilities in states like 
West Virginia, Kentucky, and Tennessee, where the opioid epidemic is particularly hard-hitting. 
 So, why can’t we just open up more facilities in these areas? Wouldn’t this eliminate the 
need for emergency department usage? Not quite. The issue with seeking out an emergency 
department rather than going to a substance abuse facility often is a result of lack of insurance 
coverage. Emergency departments cannot deny care or treatment if someone does not have 
insurance coverage, thanks to the Emergency Medical Treatment & Labor Act (“Emergency 
Medical Treatment & Labor Act (EMTALA)”, 2012). As of 2017, at least 13 states’ Medicaid 
programs do not cover methadone treatment (“State Medicaid Coverage of Methadone for 
Treatment”, 2017). 
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Figure 7 – State Medicaid Coverage of Methadone for Treatment, 2017 
(Source: Kaiser Family Foundation, published by amfAR, 2017) 
Due to the federal Institutes for Mental Diseases exclusion, federal Medicaid funds are 
prohibited from reimbursing services provided in inpatient facilities with more than 16 beds, 
except for the minority of states that have been granted waivers from this requirement (Jones 
A. et al., 2018). This leads way for future policies to advocate for increased access to MAT, but 
with these current statistics, it is clear that we have a long way to go.  
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Chapter 4 – Case Studies of Opioid-Related 
Emergency Department Visits and Future 
Implications for Strategy 
As posed using actor-network theory, emergency departments have the potential to be 
more adaptive in their practices. A number of hospitals throughout the country are 
implementing strategies to help combat opioid overdoses from occurring, both in new and 
repeat patients, highlighting the potential for change in traditional emergency medicine. Two of 
these facilities are described below. 
4.1 – Buprenorphine Induction Leading to Further Treatment: Highland Hospital, Oakland, 
California 
 Highland Hospital is a public hospital in California, owned by the Alameda Health System 
(“Alameda Health System Locations”, 2020). It is one of a few hospitals that are using their 
emergency department to begin addiction treatment. Specifically, Highland is using 
buprenorphine, a drug with similar properties to methadone in opiate detoxification and 
maintenance (Wesson and Smith, 2010). Proposed to be used for opiate-dependent patients in 
the late 1970s, clinical evidence suggests that buprenorphine is safer to use than methadone in 
an overdose situation (Jasinkski et al., 1978; Wesson and Smith, 2010). The Drug Abuse 
Treatment Act of 2000 enabled physicians in the United States to prescribe buprenorphine, 
after completing additional training, to a limited number of opiate-dependent patients (Wesson 
and Smith, 2010). The drug comes in two versions of sublingual tablets: Subutex®, which 
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contains only buprenorphine alone, and Suboxone®, a combination of buprenorphine and 
naloxone. This opiate antagonist prevents other opiates from reaching opioid receptors in the 
body, therefore blocking those opiates from producing the typical side effects. Undetectable in 
a drug test, buprenorphine is making strides in becoming a normal treatment for opioid-
dependent patients (Wesson and Smith, 2010). 
 An August 2018 article in the New York Times reports on Rhonda Hauswirth and her 
withdrawal from heroin after a day and a half of not using the drug. Ms. Hauswirth reported 
arriving at the hospital, “shaking violently,” unable to focus. Doctors gave her a sublingual dose 
of buprenorphine (more specifically, Suboxone), and Ms. Hauswirth recalled being able to 
“focus a little more” and “see straight,” also mentioning that she “had never heard of anyone 
going to an emergency room to do that” (Goodnough, 2018). Dr. Andrew Herring, the director 
of the buprenorphine program at Highland Hospital, told the New York Times, “With a single 
E.R. visit we can provide 24 to 48 hours of withdrawal suppression, as well as suppression of 
cravings. It can be this revelatory moment for people — even in the depth of crisis, in the 
middle of the night. It shows them there’s a pathway back to feeling normal” (Goodnough, 
2018). 
 Dr. Herring was influenced by a 2015 Yale School of Medicine study, which found that 
addicted patients who were given buprenorphine in the emergency room were twice as likely 
to be in treatment a month later as those who were simply handed an informational pamphlet 
with phone numbers (D’Onofrio et al., 2015). The study was key in developing Highland 
Hospital’s buprenorphine program. Highland Hospital, along with seven other Northern 
California hospitals, experimented with dispensing buprenorphine in their emergency 
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departments to jump-start addiction recovery (Goodnough, 2018). Now, California is working to 
expand this effort to emergency departments statewide as a part of their “Medication Assisted 
Treatment (MAT) Expansion” program (“CA Hub and Spoke System: MAT Expansion Project”, 
2017). 
 An adaptation of a system already used in Vermont, California’s expansion program uses 
the Hub and Spoke framework. Regions participating in the program will have a specialized 
addiction center of expertise, known as the Hub, that is an opioid treatment program (OTP).  
Each Hub is connected to a number of Spokes, which is any office or clinic with a buprenorphine 
prescriber.  Spokes will have access to a dedicated MAT team, consisting of one registered 
nurse and one licensed clinical social worker for every one hundred patients on buprenorphine 
under Medicaid. Spokes have the ability to refer complex patients to the Hub in their region for 
stabilization (“CA Hub and Spoke System: MAT Expansion Project”, 2017). 
 At the end of the article, Dr. Herring recalls a weekly clinic he holds for his patients that 
started buprenorphine in the emergency department. He details the symptoms of withdrawal 
reported by Ms. Hauswirth and others, noting the reports of feeling like there is a “war” within 
their bodies. However, the reports of “doing well” should not be taken as a sign to stop taking 
medication. Rather, buprenorphine is to be treated as a “vitamin” and must be taken every day 
for it to be successful. Herring says, “You’ve torched everything, and the medication is letting it 
grow back, and it’s going to be beautiful, but it’s going to take some time” (Goodnough, 2018). 
It is clear to me that work being done in California is an important step for bridging the 
connection between the opioid epidemic and emergency departments. 
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4.2 – The Bridge Clinic: Brigham and Women’s Hospital, Boston, Massachusetts 
 In 2018, Harvard Medical School’s major teaching hospital, Brigham and Women’s 
Hospital, opened up the Brigham Health Bridge Clinic, being co-led by psychiatrists Dr. Joji 
Suzuki and Dr. David A. Gitlin (Linke, 2018). According to their website, the Bridge Clinic is a 
“rapid-access, low barrier clinic for patients with Substance Use Disorders (SUDs), including 
alcohol, opioids, benzodiazepines, cocaine, amphetamines, etc.” that “embrace[s] a harm 
reduction and compassionate approach for patients in all stages of recovery” (“The Brigham 
Health Bridge Clinic”, 2018). The clinic provides services, including all three forms of 
medication-assisted treatment, support links via recovery coaches and social workers in an 
individualized or group setting, connections to community resources for things like food, 
housing, identification cards, employment opportunities, and education, and makes a “bridge” 
to longer-term treatment that fits each patient’s self-identified path for sustained recovery 
when an individual is ready for that transition (“The Brigham Health Bridge Clinic”, 2018). 
 In an article for The Boston Globe, nurse practitioner team manager of Brigham and 
Women’s Primary Care Associates, Longwood, Kate Takayoshi claims that the goal of the clinic 
is to goal is “to get high-risk patients started with the medications and services they need 
immediately, then help them find the right program to support their recovery” (Brigham 
Health, 2019). The opening of the clinic reduces the number of patients who are lost to follow-
up, defined as being discharged from the hospital and did not follow up to continue receiving 
outpatient treatment, and allows patients to be seen much sooner for their intake appointment 
(Brigham Health, 2019). 
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 The Substance Abuse and Mental Health Services Administration runs a collaborative 
known as the State Targeted Response Technical Assistance (STR-TA), or the Opioid Response 
Network (“STR-TA”, 2020). In report published by them, Brigham Health reports that between 
April 2018 and January 2019, 277 patients from their emergency departments were referred to 
the Bridge Clinic, with 75% of those patients presenting for at least one appointment. Of those 
75%, or 207 patients, that engaged with the Clinic, 85% remain in treatment (either at the 
Bridge Clinic or in longer-term care), emergency department visits decreased by 66% within the 
3 months after referral (for patients with 3 months of follow-up after Bridge Clinic referral), and 
inpatient admissions decreased by 60% within the 3 months after referral (for patients with 3 
months of follow-up after Bridge Clinic referral) (Herring et al., 2019). 
4.3 – Future Implications for Strategy 
 From the above two case studies, it is evident that a successful intervention of a “bridge 
program” to connect emergency department patients to long-term care would be best to allow 
hospital emergency departments to maximize performance. Obvious root causes that would 
need to be addressed are those relating to why individuals overdose in the first place. The 
overall goal would be to reduce the volume of overdoses entering the emergency department, 
which would in turn maximize performance by reducing wait times. 
 To start, based on these case studies, patients with addictions might benefit from 
physicians who specialize in addiction medicine, psychiatry, emergency medicine, or other 
similar specialties aligning to develop bridge programs. It would be helpful for them to reach 
out to existing bridge programs, like those in California or Massachusetts, to assess if their 
strategies should be duplicated or tailored in order to avoid problems encountered by either 
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program. Physicians advocacy for such funding programs could be an important impetus for 
change. With such programs in place, providers could track the success of the program by 
seeing If patients seeing at bridge clinics are following through with care, by measuring 
mortality outcomes between those at the clinic versus those not using the clinic, and ultimately 
by seeing if emergency department crowding is mitigated. 
 Both of the bridge programs described above use a harm reduction model. Harm 
reduction is defined as “policies, programs, and practices that aim to minimize negative health, 
social and legal impacts associated with drug use, drug policies and drug laws… it focuses on 
positive change and on working with people without judgement, coercion, discrimination, or 
requiring that they stop using drugs as a precondition of support” (“What is Harm Reduction”, 
2020). These bridge programs and others meet patients where they are, connect patients to 
longitudinal care, and are in a sense adapting emergency department care to the pressures of 
care necessary for opioid addiction. This inherently makes them adaptive institutions, as 
predicted by Latour. 
 However, there are many emergency departments that do not have these sort of bridge 
programs. Perhaps emergency departments are simply not the appropriate place for these 
patients to be seen. The movement to create an emergency medicine specialty was a medical 
movement, not a public health movement. It was set up to take care of individuals at a more 
efficient and appropriate level than the prior system; it was not intended for dealing with an 
epidemic, but rather emergent, non-chronic issues. It is evidently complicated for emergency 
departments to then be expected to perform public health duties while also performing their 
intended duties. However, this can also be seen as an opportunity for emergency departments 
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to become more adaptive; in taking up systems like bridge programs, emergency departments 
can expand their scope to understand the whole of the person by using harm reduction, rather 
than staying in a medical model for opioid addiction treatment. This may reveal a hole in our 
current healthcare system rather than it being the fault of emergency departments. As such, an 
understanding of social determinants of health, described in the following chapter, is relevant 
for examining why our emergency department system is the way that it is.  
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Chapter 5 – A Note on Social Determinants 
of Health 
5.1 – Social Determinants of Health 
 As defined by the World Health Organization, social determinants of health are the 
conditions in which people are born, grow, live, work and age (“About social determinants of 
health”, 2017). This includes socioeconomic status, social support networks, and access to 
healthcare. Research shows that health outcomes are driven by an array of factors, including 
underlying genetics, health behaviors, social and environmental factors, and health care. While 
there is currently no consensus in the research on the magnitude of the relative contributions 
of each of these factors to health, it is suggested that health behaviors like smoking, diet, and 
exercise, as well as socioeconomic factors are the primary drivers of health outcomes, and 
socioeconomic factors can shape individuals’ health behaviors. This translates into children who 
are born to parents who have not completed high school being more likely to live in an 
environment that poses barriers to health such as lack of safety, exposed garbage, and 
substandard housing, and barriers to solving these negative health behaviors, like a lack access 
to sidewalks, parks or playgrounds, recreation centers, or a library (Artiga and Hinton, 2018). 
 In considering social determinants of health, the majority of opioid overdoses in the U.S. 
in 2018 were done by white, non-Hispanic individuals. Black, non-Hispanic individuals saw 6,088 
opioid overdoses in 2018, and Hispanic individuals saw 4,370 opioid overdoses in the same year 
(“Opioid Overdose Deaths by Race/Ethnicity”, 2020). Looking at emergency department visits in 
2017, 70.1% of visits consisted of white individuals, 26.1% of visits were from black individuals, 
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and 15.9% were Hispanic (“NHAMCS”, 2017). Though the data I examined did not specify 
socioeconomic status, previous contributions to negative health behaviors or social support 
networks, further studies can investigate how social determinants of health truly play a role in 
the relationship between emergency department visits and opioid overdoses.  
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Chapter 6 – Conclusion 
 This thesis would not be complete without mentioning the current pandemic that is 
impacting both emergency departments and the opioid epidemic. In April 2020, I attended the 
Yale Healthcare Conference through Yale University, focused on the novel coronavirus (COVID-
19). In a panel focused on protecting vulnerable populations during this pandemic, emergency 
medicine physician Dr. Kathryn Hawk touched upon how her emergency department’s response 
to the opioid epidemic has shifted in light of COVID-19. She noted that an emergency 
department is a “safety net” within the larger healthcare system and that emergency 
departments provide care to those who otherwise have no other means of accessing 
healthcare. Since 2015, Dr. Hawk shared that Yale-New Haven Hospital has been initiating 
buprenorphine in their emergency department, noting this was a “paradigm shift in what was 
previously care traditionally siloed to outpatient care or addiction-medicine providers and 
specialists” and connecting patients to longer term follow-up care outside of the emergency 
department (Hawk et al., 2020). 
Overall, this shift in the way care is provided has become more of a patient-centered 
approach, making sure that the patient is at the heart of every decision made in their treatment 
plan. Dr. Hawk also shared that, in her experience, when a patient shows up to an emergency 
department wanting treatment and instead receives a paper prescription to seek care 
elsewhere, it is “demoralizing” to that patient’s progress toward recovery. If conversations are 
started with “How can we help you today?” rather than “Let’s get you in treatment right now,” 
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patients are more receptive to a physician’s ideas, forming a provider-patient alliance (Hawk et 
al., 2020). 
In tying this all together with the COVID-19 pandemic, Dr. Hawk describes prior 
experience of patients with addiction being traditionally negative experiences in emergency 
departments, with this environment being a negative and unwelcoming place for them to 
receive care. This is particularly relevant to the current pandemic because a lot of the care 
provided to these patients in emergency departments involves sit-down conversations with 
patients, sharing spaces, and with physical distancing restrictions in place to prevent the spread 
of the virus, emergency departments are having to figure out how to still provide these spaces 
and services for patients. With decreased access to outpatient services as a result of the 
pandemic, it is particularly important that emergency departments are available to solve unmet 
needs, including mental health referrals, medical treatment, and substance use treatment, and 
also extend buprenorphine prescriptions to account for closures of facilities that normally 
provide access to that. This population of patients seeking care is even more vulnerable, and it 
is important that other providers are aware of this so that those recovering do not fall through 
the cracks of our already stressed medical system (Hawk et al., 2020). 
As such, our current events are highlighting even more the importance of the ever-
evolving relationship between emergency departments and the opioid epidemic, and how the 
opioid epidemic poses challenges and opportunities for emergency departments to assess and 
improve their performance under duress. For many people, this is the first virus they have seen 
that has scaled to the level that COVID-19 has. Many, if not all healthcare systems are being 
impacted due to the nature of this virus, deepening already existing vulnerabilities in 
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populations throughout the world. Emergency departments are becoming more strained 
dealing with not only a novel virus but also previously present health crises. In the case of 
emergency departments and the opioid epidemic, future work is to be done to make sure that 
if patients do choose to seek out care in emergency department, those providers are fully 
prepared to deliver high-quality, patient-centered care, even in times of crisis.  
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